SCHEMBL7207019

SCHEMBL7207019

[CH2]C/C=C\c1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.48
CYP1A2 P05177 2/20 0.45
KCNH2 Q12809 2/20 0.43
HSD17B10 Q99714 2/20 0.42
FBP1 P09467 1/20 0.42
GRIK1 P39086 1/20 0.41
GRIK2 Q13002 1/20 0.41
GRIK3 Q13003 1/20 0.41
ALOX5 P09917 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
NFE2L2 Q16236 1/20 0.39
LMNA P02545 1/20 0.38
CYP2A6 P11509 1/20 0.38
MAOB P27338 2/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2092197 1.00 AHR (0.48) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL2092199 1.00 AHR (0.48) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL2089772 0.82 AHR (0.45) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL2089771 0.82 AHR (0.45) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL29135539 0.79 AHR (0.46) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL2092628 0.79 KCNH2 (0.42) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL2092631 0.79 KCNH2 (0.42) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL73285 0.78 AHR (0.50) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL73286 0.78 AHR (0.50) AHRCYP1A2KCNH2HSD17B10FBP1
SCHEMBL7428113 0.76 NFE2L2 (0.50) FBP1GRIK1GRIK2PTGS1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922050-B1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LAB (US) 2003-07-30 EP claimed
EP-0922050-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1999-06-16 EP claimed
US-5750510-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1998-05-12 US claimed
WO-1997042205-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1997-11-13 WO claimed
EP-0922050-B1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LAB (US) 2003-07-30 EP disclosed
EP-0922050-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1999-06-16 EP disclosed
US-5750510-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1998-05-12 US disclosed
WO-1997042205-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1997-11-13 WO disclosed